These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23597048)

  • 21. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
    Crawford J
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.
    Dowell JE; Minna JD
    Nat Clin Pract Oncol; 2004 Nov; 1(1):2-3. PubMed ID: 16264773
    [No Abstract]   [Full Text] [Related]  

  • 23. EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report.
    Huang MJ; Lim KH; Tzen CY; Hsu HS; Yen Y; Huang BS
    Lung Cancer; 2005 Sep; 49(3):413-5. PubMed ID: 15913841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
    Smith J
    Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
    Lopes Gde L
    IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor mutations in lung cancer.
    Sharma SV; Bell DW; Settleman J; Haber DA
    Nat Rev Cancer; 2007 Mar; 7(3):169-81. PubMed ID: 17318210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era begins.
    Remon J; Morán T; Majem M; Reguart N; Dalmau E; Márquez-Medina D; Lianes P
    Cancer Treat Rev; 2014 Feb; 40(1):93-101. PubMed ID: 23829935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting epidermal growth factor receptor: central signaling kinase in lung cancer.
    Yoshida T; Zhang G; Haura EB
    Biochem Pharmacol; 2010 Sep; 80(5):613-23. PubMed ID: 20519133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.
    Santarpia M; Altavilla G; Salazar MF; Magri I; Pettineo G; Benecchi S; Rosell R
    Expert Rev Respir Med; 2011 Jun; 5(3):413-24. PubMed ID: 21702662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line therapy of mutated non-small cell lung cancer: an update.
    Stöhlmacher-Williams J
    Onkologie; 2012; 35(5):293-9. PubMed ID: 22868512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapy for non-small cell lung cancer.
    Toloza EM; D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker testing in non-small cell lung cancer: a clinician's perspective.
    Bernicker E
    Arch Pathol Lab Med; 2015 Apr; 139(4):448-50. PubMed ID: 25166873
    [No Abstract]   [Full Text] [Related]  

  • 33. [Research progress of targeted therapy in non-small cell lung cancer brain metastases].
    Jiang T; Zhou C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):824-8. PubMed ID: 25404274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized therapy for lung cancer.
    Moreira AL; Eng J
    Chest; 2014 Dec; 146(6):1649-1657. PubMed ID: 25451351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Targeted Therapies Are Changing Treatment for Non-Small Cell Lung Cancer.
    Becze E
    ONS Connect; 2016 Feb; 31(2):24-5. PubMed ID: 26930998
    [No Abstract]   [Full Text] [Related]  

  • 36. Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
    Albaba H; Lim C; Leighl NB
    Pharmacoeconomics; 2017 Dec; 35(12):1195-1209. PubMed ID: 28861770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular targeted therapy in lung cancer.
    Fujioka N; Bitterman PB
    Minn Med; 2012 Oct; 95(10):38-41. PubMed ID: 23193704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Not Available].
    Evers G; Mohr M; Kerkhoff A; Lenz G; Wiewrodt R; Schmidt LH
    Dtsch Med Wochenschr; 2017 Oct; 142(20):1531-1534. PubMed ID: 29017211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer. Dacomitinib: getting on target after negative ARCHER trial.
    Hutchinson L
    Nat Rev Clin Oncol; 2015 Jan; 12(1):3. PubMed ID: 25421284
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 3. Chemotherapy for patients with non-small cell lung cancer, 2) Driver mutation and molecular-targeted therapy in lung cancer].
    Maemondo M
    Nihon Naika Gakkai Zasshi; 2014 Jun; 103(6):1314-21. PubMed ID: 25151796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.